JNJ

Johnson & Johnson
D

JNJ

Arincen70/100B
285.92
USD
2.31
(0.81%)
Market Open
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 2.91Revenue estimate 26.42B
OverviewFinancialsSignalsForecastEarningsDividendsCompany

Johnson & Johnson revenue 1985–2026

Johnson & Johnson's revenue in Q3 FY2026, the three months to 27 September 2026, was 25.40B USD, up 5.9% on the same quarter a year before. Johnson & Johnson's revenue over the last twelve months was 99.34B USD, up 7.8% on the twelve months before. In fiscal year 2025 it was 94.19B USD, up 6.0% on the year before.

Last updated 7 Nov 2026 · Next report 26 Jan 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM27 Sept 202699.34B+7.80%68.35B16.10B
FY202528 Dec 202594.19B+6.05%63.94B26.80B
FY202429 Dec 202488.82B+4.30%61.35B14.07B
FY202331 Dec 202385.16B+6.46%58.61B35.15B
FY20221 Jan 202379.99B+1.59%55.39B17.94B
FY20212 Jan 202278.74B-4.65%55.34B20.88B
FY20203 Jan 202182.58B+0.64%54.16B14.71B
FY201931 Dec 201982.06B+0.59%54.50B15.12B
FY201831 Dec 201881.58B+6.71%54.49B15.30B
FY201731 Dec 201776.45B+6.34%51.01B1.30B
FY201631 Dec 201671.89B+2.59%50.10B16.54B
FY201531 Dec 201570.07B-5.73%48.54B15.41B
FY201431 Dec 201474.33B+4.23%51.59B16.32B
FY201331 Dec 201371.31B+6.08%48.97B13.83B
FY201231 Dec 201267.22B+3.37%45.57B10.85B
FY201131 Dec 201165.03B+5.59%44.67B9.67B
FY201031 Dec 201061.59B-0.50%42.80B13.33B
FY200931 Dec 200961.90B-2.90%43.45B12.27B
FY200831 Dec 200863.75B+4.34%45.24B12.95B
FY200731 Dec 200761.10B+14.57%43.34B10.58B
FY200631 Dec 200653.32B+5.56%38.27B11.05B
FY200531 Dec 200550.51B+6.69%36.50B10.06B
FY200431 Dec 200447.35B+13.10%33.87B8.18B
FY200331 Dec 200341.86B+15.33%29.69B7.20B
FY200231 Dec 200236.30B+12.32%25.85B6.60B
FY200131 Dec 200132.32B+10.78%22.74B5.67B
FY200031 Dec 200029.17B+4.16%20.22B4.95B
FY199931 Dec 199928.01B+16.72%19.51B4.27B
FY199831 Dec 199824.00B+6.04%17.68B3.00B
FY199731 Dec 199722.63B+4.67%16.54B3.30B
FY199631 Dec 199621.62B+14.74%15.61B2.89B
FY199531 Dec 199518.84B+19.75%13.46B2.40B
FY199431 Dec 199415.73B+11.29%11.16B2.01B
FY199331 Dec 199314.14B+2.80%9.96B1.79B
FY199231 Dec 199213.75B+10.49%9.64B1.03B
FY199131 Dec 199112.45B+10.82%8.74B1.46B
FY199031 Dec 199011.23B+15.12%7.77B1.14B
FY198931 Dec 19899.76B+8.41%6.69B1.08B
FY198831 Dec 19889.00B+12.33%6.10B974.00M
FY198731 Dec 19878.01B+14.41%5.41B833.00M
FY198631 Dec 19867.00B+9.06%4.65B329.50M
FY198531 Dec 19856.42B—4.08B613.70M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Johnson & Johnson revenue growth by segment

Q3 FY2026 against Q3 FY2025

Innovative Medicine16.76B
+7.7%
MedTech8.64B
+2.5%

Johnson & Johnson revenue by segment over time

Innovative Medicine MedTech Consumer Pharmaceutical Medical Devices
Fiscal yearInnovative MedicineMedTechConsumerPharmaceuticalMedical Devices
FY202560.40B +6.0%33.79B +6.1%— — —
FY202456.96B +4.0%31.86B +4.8%— — —
FY202354.76B +4.2%30.40B +10.8%— — —
FY202252.56B 27.43B 14.95B +2.2%— —
FY2021— — 14.64B +1.3%52.08B +15.3%27.06B +17.9%
FY2020— — 14.45B +4.0%45.18B 22.96B
FY201942.20B +3.6%25.96B -3.8%13.90B +0.3%— —
FY201840.73B +12.4%26.99B +1.5%13.85B +1.8%— —
FY201736.26B +8.3%26.59B +5.9%13.60B +2.2%— —
FY201633.46B 25.12B 13.31B -1.5%— —

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Johnson & Johnson's revenue

Source: Financial Modeling PrepVerified against SEC filings